High-dose-rate interstitial computed tomography-based brachytherapy for the treatment of cervical cancer: Early results

Our approach of a single implantation procedure followed by five fractions of HDRBT was well tolerated with early results demonstrating a moderate response and local control rate with acceptable toxicities.